Cardiotoxicity of Anticancer Treatments: Epidemiology, Detection, and Management
Curigliano G, Cardinale D, Dent S, Criscitiello C, Aseyev O, Lenihan D, Cipolla CM
CA Cancer J Clin. 2016 Jul;66(4):309-25
CARDIONCOLOGY.ORG ABSTRACT:
Patients may experience adverse cardiovascular events related to their cancer treatment or as a result of an exacerbation of underlying cardiovascular disease.
With longer periods of survival, late effects of cancer treatment may become clinically evident years or decades after completion of therapy.
The discipline of cardio-oncology has developed as multi-disciplinary response to the strategies necessary to prevent or mitigate cardiovascular damage from cancer treatment.
This review focuses on the common cardiovascular issues that may arise during or after cancer therapy, the detection and monitoring of cardiovascular injury and the best management principles to protect against or minimize cardiotoxicity during the spectrum of cancer treatment strategies.
© All Rights Reserved
Image source: https://4rai.com/blog/6-misconceptions-that-increase-your-risk-of-heart-disease